Scientific Advice Program Offerings

We offer Scientific Advice on both the clinical and economic aspects of drug development.

Canada’s Drug Agency (CDA-AMC) offers the following:

• Standard Scientific Advice (CDA-AMC only)
• Customized Scientific Advice (CDA-AMC only)
• Parallel Scientific Advice with CDA-AMC and Canada’s regulatory body, Health Canada (available on a case-by-case basis)
• Parallel Scientific Advice with CDA-AMC and the UK’s National Institute for Health and Care Excellence

Our health technology assessment partner in Quebec, Institut national d'excellence en santé et en services sociaux will be invited to join the parallel process with CDA-AMC and Health Canada in an observatory role.

Please refer to: Parallel Scientific Advice